Catalyst Wire Dossier Catalyst Wire Dossier

Medicago recombinant coronavirus-like particle COVID-19 vaccine

· Medicago
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Medicago recombinant coronavirus-like particle COVID-19 vaccine, covering 2023-06-02 to 2023-06-02. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study to Evaluate the Lot Consistency of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine [Phase 3]

See pricing